Second Sales Contract
Brain+ closes its second sales contract for CST Therapist Companion with a dementia care center in Gladsaxe municipality Brain+ announces to have closed a second sales contract for the company’s new digital dementia product, CST – Therapist Companion. The sales contract is a 3-year contract, giving therapists in the municipal dementia care facility, Bakkegården demensboliger, in Gladsaxe access […]
BRAIN+ IN DEMENTIA CAFES IN GERMANY
Malteser Hilfsdienst and Brain+ begin collaboration to offer people with dementia access to CST in special dementia cafes in Germany Brain+ and Malteser Hilfsdienst has started a collaboration to help people with dementia in Germany. The Malteser Hilfsdienst is one of Germany’s major charitable service providers with over 1 million members and sponsors, and the organization is a major player in offering […]
New Digital Health Strategy in Germany
Germany sets a new digitalization strategy further supporting the adoption of digital therapeutics in Europe’s largest healthcare market This month the German Ministry of Health’s shared its new healthcare digitalization strategy, “Gemeinsam Digital”, together with a vision for an integrated digital health ecosystem in Germany. The country’s strong focus on digital solutions represents a great opportunity for Brain+ and other suppliers of digital therapeutics by enabling easier […]
Cognitive Stimulation Therapy (CST) enhances the effects of Alzheimer’s disease medicine
Cognitive Stimulation Therapy (CST) enhances the effects of Alzheimer’s disease medicine A key finding from the recently released 2nd systematic Cochrane review (Woods et al., 2023) is the confirmation that medication combined with CST results in significantly larger benefits over and above that of medication alone. More specifically, patients that take part in CST demonstrate […]
EU GRANT
Respected dementia experts and Brain+ get EU grant to research how to optimize digital at-home treatments for people with dementia The EU Joint Programme – Neurodegenerative Disease Research has granted 496,000SEK (or 48,405 euros) to an international research consortium consisting of the University of York Europe Campus, Greece, University of Gothenburg, Sweden, Brain+ A/S, Denmark, […]
MATSUMAE BUSINESS CUP
Brain+ showcases its digital dementia products At the Danish-Japanese Welfare and Health Tech Business Conference Brain+ is part of a group of Danish welfare and health tech companies that have been invited to present their products and solutions at the Matsumae Cup Business conference. The business cup is organized and held in Vejle, Denmark on […]
CONCLUSION EU PROJECT & VALIDATION OF TWO TECHNOLOGIES
Successful conclusion of EU project Alzheimer’s Detect & Prevent with early validation of two Brain+ DTx technologies and extra funding The information communicated in this announcement is “inside information” for the purposes of article 7 of the Market Abuse Regulation 596/2014 The 3.5-year Alzheimer’s Detect & Prevent project (ADDP) funded with €3.5 million by the EU […]
Brain+ completes Swedish research version of its dementia product
Brain+ completes Swedish research version of its dementia product with the Research Institutes of Sweden and extends the collaboration A strong Swedish partner research network Brain+ has over the last three years entered multiple Alzheimer’s focused research and innovation projects with strong Swedish partners, including Research Institutes of Sweden (RISE), University of Gothenburg: Department of […]
Implementation of an ISO 13485 for Medical Devices
Brain+ completes the implementation of an ISO 13485 Quality Management System for Medical Devices Brain+ has successfully completed the implementation of an ISO 13485-compliant Quality Management System (QMS). Such a system helps to set standards to ensure stringent processes throughout every step of a medical device product’s life cycle and thus to maintain a high […]
Leading dementia researcher joins Brain+
Brain+ adds new clinical and development competences To accelerate and support market access of its digital dementia product portfolio Rising star clinical dementia researcher to join the company in a new position as Clinical Director Recently, development was also strengthened with a Quality Manager and a Clinical Research Associate The new hires represent a significant […]
